[1
]
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota; St. George's,
University of London, London, United Kingdom.
[2
]
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
[3
]
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine
at Mount Sinai, New York, New York; Clinical Trials Center, Cardiovascular Research
Foundation, New York, New York. Electronic address: roxana.mehran@mssm.edu.
[4
]
LeBauer Cardiovascular Research Foundation/Cone Health, Greensboro, North Carolina.
[5
]
Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; New
York Methodist Hospital, Brooklyn, New York.
[6
]
Center for Interventional Vascular Therapy, Division of Cardiology, Columbia University
Medical Center, New York, New York.
[7
]
Yale Cardiovascular Research Program, Yale University Medical Center, New Haven, Connecticut.
[8
]
Department of Cardiology and Pneumology, Helios Amper-Klinikum, Dachau, Germany.
[9
]
Cardiology Division, Rabin Medical Center, Petah-Tikva, Israel.
[10
]
Ospedale Papa Giovanni XXIII, Bergamo, Italy.
[11
]
Department of Interventional Cardiology, Jagiellonian University, Krakow, Poland.
[12
]
Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Center
for Interventional Vascular Therapy, Division of Cardiology, Columbia University Medical
Center, New York, New York.